A Phase II Study of Nivolumab and Ipilimumab with Radiation Therapy in Patients with Metastatic, Microsatellite Stable Colorectal Cancer. (PubMed, Clin Cancer Res) - Oct 2, 2026 - "The combination of immune-modulating, non-ablative doses of radiation therapy with ipilimumab and nivolumab has selective clinical activity in refractory MSS CRC, with responses concentrated primarily in patients without active liver metastases."
Journal • P2 data • Colorectal Cancer • Microsatellite Instability • Oncology • Solid Tumor • MSI
|
|
Aparna R Parikh; Arnav Mehta; Benjamin L Schlechter; Beow Y Yeap; Bruce J Giantonio; David P Ryan; David Ting; Elizabeth Kantrowitz; Hannah J Roberts; Jeffrey A Meyerhardt; Jeffrey W Clark; Jennifer Y Wo; Jill N Allen; Julie L Koenig; Katharine Zecca; Kimberly Perez; Lawrence S Blaszkowsky; Leontios Pappas; Lorraine C Drapek; Ryan Corcoran; Samuel J Klempner; Sydney D Ludes; Theodore S Hong
|